P.2.e.035 Effect of aripiprazole adjunctive to lamotrigine on manic and mixed subpopulations: 52- week, double-blind, randomised relapse prevention trial von Fountoulakis, K.N, Rahman, Z, Fyans, P, Eudicone, J.M, Forbes, R.A, Baker, R.A, Carlson, B.X

Volltext

P.2.e.023 Long -term metabolic effects of aripiprazole adjunctive to lithium, valproate or lamotrigine von De Hert, M, Kemp, D.E, Fyans, P, Rahman, Z, Marler, S.V, Eudicone, J.M, Baker, R.A, Forbes, R.A, Carlson, B.X

Volltext

P.2.e.022 Does shorter vs. longer stabilisation in patients with bipolar I disorder predict relapse? von Vieta, E, Bowden, C.L, Masand, P.S, Everitt, A.L, Rahman, Z, Marler, S.V, Eudicone, J.M, Baker, R.A, Forbes, R.A, Carlson, B.X

Volltext

Investigation into the Long-term Metabolic Effects of Aripiprazole Adjunctive to Lithium, Valproate, or Lamotrigine von Kemp, D.E, De Hert, Marc, Rahman, Z, Fyans, P, Eudicone, J.M, Marler, S.V, Baker, R.A, Forbes, R.A, Carlson, B.X

Volltext

Long-term metabolic effects of aripiprazole adjunctive to lithium, valproate or lamotrigine von De Hert, Marc, Kemp, D.E, Fyans, P, Rahman, Z, Marler, S.V, Eudicone, J.M, Baker, R.A, Forbes, R.A

Volltext